Skip to main content

Table 1 Five papers provided 89Zr-mAb plasma/serum activity concentration data

From: Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study

 

89Zr-mAb

Subject group

Sampling

References

1

89Zr-huJ591

Metastatic prostate cancer

Serum

Pandit-Taskar et al. [10]

2

89Zr-trastuzumab

Esophagogastric cancer

Serum

O’Donoghue et al. [11]

3

89Zr-pertuzumab

Breast cancer

Serum

Ulaner et al. [12]

4

89Zr-DFO-MSTP2109A

Prostate cancer

Plasma

O’Donoghue et al. [13]

5

89Zr-AlbudAb

Healthy volunteers

Plasma

Thorneloe et al. [14]